Safety evaluation of the food enzym endo‐1,4‐β‐xylanase from the genetically modified Bacillus subtilis strain AR‐153 Authors: EFSA Panel on Food Enzymes (FEZ), Holger Zorn, José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize L. M. Solano, Monika Sramkova, Henk Van Loveren, Laurence Vernis, Jaime Aguilera, Giulio di Piazza, Yi Liu Published: 2024 ABSTRACT AbstractThe food enzyme endo‐1,4‐β‐xylanase (4‐β‐d‐xylan xylanohydrolase; EC 3.2.1.8) is produced with the genetically modified Bacillus subtilis strain AR‐153 by AB Enzymes GmbH. The genetic modifications do not give rise to safety concerns. The production strain meets the requirements for the qualified presumption of safety (QPS) approach. The food enzyme is free from viable cells of the production organism and its DNA. It is intended to be used in four food manufacturing processes. Since residual amounts of total organic solids (TOS) are removed during one food manufacturing process, dietary exposure was only calculated for the remaining three processes. Exposure was estimated to be up to 0.463 mg TOS/kg body weight per day in European populations. Given the QPS status of the production strain and the absence of concerns resulting from the food enzyme manufacturing process, toxicity tests were considered unnecessary by the Panel. A search for homology of the amino acid sequence of the food enzyme to known allergens was made and no match was found. The Panel considered that the risk of allergic reactions upon dietary exposure cannot be excluded, but the likelihood is low. Based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns, under the intended conditions of use. INTRODUCTION Article 3 of the Regulation (EC) No 1332/2008 1 provides definition for ‘food enzyme’ and ‘food enzyme preparation’. ‘Food enzyme’ means a product obtained from plants, animals or microorganisms or products thereof including a product obtained by a fermentation process using microorganisms: (i) containing one or more enzymes capable of catalysing a specific biochemical reaction; and (ii) added to food for a technological purpose at any stage of the manufacturing, processing, preparation, treatment, packaging, transport or storage of foods. ‘Food enzyme preparation’ means a formulation consisting of one or more food enzymes in which substances such as food additives and/or other food ingredients are incorporated to facilitate their storage, sale, standardisation, dilution or dissolution. Before January 2009, food enzymes other than those used as food additives were not regulated or were regulated as processing aids under the legislation of the Member States. On 20 January 2009, Regulation (EC) No 1332/2008 on food enzymes came into force. This Regulation applies to enzymes that are added to food to perform a technological function in the manufacture, processing, preparation, treatment, packaging, transport or storage of such food, including enzymes used as processing aids. Regulation (EC) No 1331/2008 2 established the European Union (EU) procedures for the safety assessment and the authorisation procedure of food additives, food enzymes and food flavourings. The use of a food enzyme shall be authorised only if it is demonstrated that: it does not pose a safety concern to the health of the consumer at the level of use proposed;there is a reasonable technological need;its use does not mislead the consumer. it does not pose a safety concern to the health of the consumer at the level of use proposed; it does not pose a safety concern to the health of the consumer at the level of use proposed; there is a reasonable technological need; there is a reasonable technological need; its use does not mislead the consumer. its use does not mislead the consumer. All food enzymes currently on the EU market and intended to remain on that market, as well as all new food enzymes, shall be subjected to a safety evaluation by the European Food Safety Authority (EFSA) and approval via an EU Community list. Background and Terms of Reference as provided by the requestor Background as provided by the European Commission Only food enzymes included in the Union list may be placed on the market as such and used in foods, in accordance with the specifications and conditions of use provided for in Article 7(2) of Regulation (EC) No 1332/2008 on food enzymes. On 18 November 2022, a new application has been introduced by the applicant “AB Enzymes GmbH” for the authorisation of the food enzyme endo‐1,4‐β‐xylanase from a genetically modified strain of Bacillus subtilis (strain AR‐153). Terms of Reference The European Commission requests the European Food Safety Authority to carry out the safety assessment and the assessment of possible confidentiality requests of the following food enzyme: endo‐1,4‐β‐xylanase from a genetically modified strain of Bacillus subtilis (strain AR‐153), in accordance with Regulation (EC) No 1331/2008 establishing a common authorisation procedure for food additives, food enzymes and food flavourings. DATA AND METHODOLOGIES Data The applicant has submitted a dossier in support of the application for authorisation of the food enzyme endo‐1,4‐β‐xylanase from a genetically modified Bacillus subtilis (strain AR‐153). Additional information, requested from the applicant during the assessment process on 30 October 2023, was received on 13 May 2024. (see ‘Documentation provided to EFSA’). Methodologies The assessment was conducted in line with the principles described in the EFSA ‘Guidance on transparency in the scientific aspects of risk assessment’ (EFSA, 2009) and following the relevant guidance documents of the EFSA Scientific Committee. The ‘Scientific Guidance for the submission of dossiers on Food Enzymes’ (EFSA CEP Panel, 2021) and the ‘Food manufacturing processes and technical data used in the exposure assessment of food enzymes' (EFSA CEP Panel, 2023) have been followed for the evaluation of the application. Public consultation According to Article 32c(2) of Regulation (EC) No 178/2002 3 and to the Decision of EFSA's Executive Director laying down the practical arrangements on pre‐submission phase and public consultations, EFSA carried out a public consultation on the non‐confidential version of the technical dossier from 17 May to 7 June 2024, 4 for which no comments were received. ASSESSMENT IUBMB nomenclatureEndo‐1,4‐β‐xylanaseSystematic name4‐β‐d‐xylan xylanohydrolaseSynonymsendo‐(1–4)‐β‐xylan 4‐xylanohydrolase; xylanase; β‐1,4‐xylanase; β‐xylanaseIUBMB NoEC 3.2.1.8CAS No9025‐57‐4EINECS No232‐800‐2 IUBMB nomenclatureEndo‐1,4‐β‐xylanaseSystematic name4‐β‐d‐xylan xylanohydrolaseSynonymsendo‐(1–4)‐β‐xylan 4‐xylanohydrolase; xylanase; β‐1,4‐xylanase; β‐xylanaseIUBMB NoEC 3.2.1.8CAS No9025‐57‐4EINECS No232‐800‐2 Endo‐1,4‐β‐xylanases catalyse the random hydrolysis of 1,4‐β‐d‐xylosidic linkages in xylans (including arabinoxylans) resulting in the generation of (1–4)‐β‐d‐xylan oligosaccharides. The food enzyme under assessment is intended to be used in four food manufacturing processes as described in the EFSA Guidance (EFSA CEP Panel, 2023): processing of cereals and other grains for the production of (1) baked products, (2) cereal‐based products other than baked, (3) starch and gluten fractions and (4) brewed products. Source of the food enzyme The enzyme is produced with the genetically modified bacterium Bacillus subtilis strain AR‐153 (■■■■■), which is deposited at the culture collection of the ■■■■■ with the deposit number ■■■■■. 5 The production strain was identified as B. subtilis by whole genome sequence (WGS) analysis, showing an average nucleotide identity of ■■■■■ and by phylogenetic analysis. 6 The species B. subtilis is included in the list of organisms for which the qualified presumption of safety (QPS) may be applied, provided that the absence of acquired antimicrobial resistance (AMR) genes and toxigenic activity are verified for the specific strain used (EFSA BIOHAZ Panel, 2022) and the genetic modifications do not raise concerns. The production strain B. subtilis AR‐153 was shown not to be toxic to VERO cells. 7 The WGS of the production strain was interrogated for the presence of antimicrobial resistance genes using two databases ■■■■■. No genes of concern were identified. Characteristics of the parental and recipient microorganisms ■■■■■. 8 Characteristics of introduced sequences ■■■■■ ■■■■■. 9 Description of the genetic modification process The aim of the genetic modification was to enable the production strain to overproduce endo‐1,4‐β‐xylanase. ■■■■■ ■■■■■. 10 Safety aspects of the genetic modification The technical dossier contains all necessary information on the recipient microorganism, the donor organism and the genetic modification process. The production strain B. subtilis strain AR‐153 differs from the parental strain in its capacity to overproduce endo‐1,4‐β‐xylanase ■■■■■. No issues of concern arising from the genetic modifications were identified by the Panel. As all other qualifications have been met, the production strain meets the requirements of the QPS approach for safety assessment. Production of the food enzyme The food enzyme is manufactured according to the Food Hygiene Regulation (EC) No 852/2004, 11 with food safety procedures based on Hazard Analysis and Critical Control Points, and in accordance with current Good Manufacturing Practice. 12 The production strain is grown as a pure culture using a typical industrial medium in a ■■■■■ fermentation system with conventional process controls in place. After completion of the fermentation the solid biomass is removed from the fermentation broth by filtration. The filtrate containing the enzyme is then further purified and concentrated, including an ultrafiltration step in which enzyme protein is retained, while most of the low molecular mass material passes the filtration membrane and is discarded. The applicant provided information on the identity of the substances used to control the fermentation and in the subsequent downstream processing of the food enzyme. 13 The Panel considered that sufficient information has been provided on the manufacturing process and the quality assurance system implemented by the applicant to exclude issues of concern. Characteristics of the food enzyme Properties of the food enzyme The endo‐1,4‐β‐xylanase is a ■■■■■ polypeptide chain of ■■■■■ amino acids. The molecular mass of the mature protein, calculated from the amino acid sequence, is ■■■■■ kDa. 14 The food enzyme was analysed by sodium dodecyl sulfate‐polyacrylamide gel electrophoresis. A consistent protein pattern was observed across all batches. ■■■■■. 15 No other enzyme activities were reported. The in‐house determination of endo‐1,4‐β‐xylanase activity ■■■■■ The activity is expressed in xylanase units (XylH)/g. One XylH is defined as the amount of enzyme that releases 1 μmol of xylose equivalents per minute under the assay conditions. 16 The food enzyme has a temperature optimum ■■■■■ 17 and a pH optimum ■■■■■. 18 Thermostability was tested ■■■■■ and no activity was detected after ■■■■■. 19 Chemical parameters Data on the chemical parameters of the food enzyme were provided for three batches (Table 1). The mean total organic solids (TOS) of the three batches was 18.6% and the mean enzyme activity/TOS ratio was 4.3 XylH/mg TOS. 20 TABLE 1Composition of the food enzyme.ParametersUnitBatches123 Endo‐1,4‐β‐xylanase activity XylH/g a 1020654743 Protein %6.76.26.3 Ash %1.11.01.1 Water %80.380.580.1 Total organic solids (TOS) b %18.618.518.8 Activity/TOS ratio XylH/mg TOS5.53.54.0 a XylH: Xylanase units (see Section 3.3.1). b TOS calculated as 100% – % water – % ash. Composition of the food enzyme. XylH: Xylanase units (see Section 3.3.1). TOS calculated as 100% – % water – % ash. Purity The lead content in the three commercial batches was below 5 mg/kg which complies with the specification for lead as laid down in the general specifications for enzymes used in food processing (FAO/WHO, 2006). In addition, arsenic, mercury and cadmium concentrations were below the limits of detection of the employed methods. 21 , 22 The food enzyme complies with the microbiological criteria for total coliforms, Escherichia coli and Salmonella, as laid down in the general specifications for enzymes used in food processing (FAO/WHO, 2006). In addition, the food enzyme was tested for the presence of Staphylococcus aureus (absent in 25 g), Bacillus cereus (< 100 cfu/g) and sulfite reducing anaerobic bacteria (< 10 cfu/g). No antimicrobial activity was detected in any of the tested batches. 23 The Panel considered that the information provided on the purity of the food enzyme was sufficient. Viable cells and DNA of the production strain The absence of viable cells of the production strain in the food enzyme was demonstrated in three independent batches analysed in triplicate. ■■■■■. 24 ■■■■■. A positive control was included. The absence of recombinant DNA in the food enzyme was demonstrated by polymerase chain reaction analysis of three batches in triplicate. No DNA was detected with primers that would amplify a ■■■■■ fragment ■■■■■, with a limit of detection of 10 ng spiked DNA/g food enzyme. 25 Toxicological data As the production strain qualifies for the QPS approach of safety assessment and no issue of concern arising from the production process of the food enzyme was identified (see Sections 3.1, 3.2 and 3.3), the Panel considered that no toxicological studies other than the assessment of allergenicity were necessary (EFSA CEP Panel, 2021). Allergenicity The allergenicity assessment considered only the food enzyme and not additives, carriers or other excipients that may be used in the final formulation. The potential allergenicity of the endo‐1,4‐β‐xylanase produced with B. subtilis strain AR‐153 was assessed by comparing its amino acid sequence with those of known allergens (EFSA GMO Panel, 2010). Using higher than 35% identity in a sliding window of 80 amino acids as the criterion, no match was found using the AllergenOnline database. 26 No reports on oral or respiratory sensitisation or elicitation reactions of the endo‐1,4‐β‐xylanase under assessment have been published. Respiratory allergy, e.g. baker's asthma, following occupational exposure to xylanase has been described in some epidemiological studies (Elms et al., 2003; Martel et al., 2010) and case reports (Baur et al., 1998; Merget et al., 2001). However, several studies have shown that individuals respiratorily sensitisised to a food enzyme are usually able to ingest the corresponding enzyme without acquiring clinical symptoms of food allergy (Armentia et al., 2009; Cullinan et al., 1997; Poulsen, 2004). ■■■■■, a known source of allergens, is present in the media fed to the microorganism. During the fermentation process, ■■■■■ will mostly be degraded and utilised by the microorganisms for cell growth, cell maintenance and production of enzyme protein. However, the Panel considered that residual amounts of potentially allergenic proteins could still be present in the food enzyme, resulting in trace amounts in the final foods. In conclusion, the Panel considered that the risk of allergic reactions upon dietary exposure to this food enzyme cannot be excluded, but the likelihood is low. Dietary exposure Intended use of the food enzyme The food enzyme is intended to be used in four food manufacturing processes at the recommended use levels summarised in Table 2. TABLE 2Intended uses and recommended use levels of the food enzyme as provided by the applicant. 27 Food manufacturing process a Raw material (RM)Recommended use level (mg TOS/kg RM) b Processing of cereals and other grains Production of starch and gluten fractions Cereals65–128 Production of baked products Flour0.2–7 Production of cereal‐based products other than baked Flour0.2–7 Production of brewed products Cereals49–98 Abbreviation: TOS, total organic solids. a The name has been harmonised by EFSA in accordance with the ‘Food manufacturing processes and technical data used in the exposure assessment of food enzymes’ (EFSA CEP Panel, 2023). b The numbers in bold were used for calculation. Intended uses and recommended use levels of the food enzyme as provided by the applicant. 27 Production of starch and gluten fractions Production of starch and gluten fractions Production of baked products Production of baked products Production of cereal‐based products other than baked Production of cereal‐based products other than baked Production of brewed products Production of brewed products Abbreviation: TOS, total organic solids. The name has been harmonised by EFSA in accordance with the ‘Food manufacturing processes and technical data used in the exposure assessment of food enzymes’ (EFSA CEP Panel, 2023). The numbers in bold were used for calculation. For the production of baked and other cereal‐based products, the food enzyme is added to flour during the preparation of dough. 28 It is used to hydrolyse (arabino)xylans, modulating the interaction with gluten and water, thus contributing to reduce the viscosity of the dough. The decrease in dough viscosity facilitates the handling of the dough, resulting in more uniform products with increased volume and an improved crumb structure. The food enzyme–TOS remain in the final processed foods. For the production of starch and gluten fractions, the food enzyme is added to the cereals to aid the separation into starch and gluten fractions. 29 Repeated washing steps remove the food enzyme–TOS from the final starch or gluten (EFSA CEP Panel, 2023). For the production of brewed products, the food enzyme is added at the beginning of the mashing step. The food enzyme promotes the release of starch and protein, increasing the brewing yield. It also reduces viscosity and turbidity, which aids beer filtration. 30 The food enzyme–TOS remain in the final brewed products. Based on data provided on thermostability (see Section 3.3.1) and the downstream processing steps applied in the food manufacturing processes, the Panel considered that the food enzyme may remain in its active form in the three food manufacturing processes where the food enzyme–TOS remain, depending on the processing conditions. Dietary exposure estimation In accordance with the guidance document (EFSA CEP Panel, 2021), dietary exposure was calculated for the three food manufacturing processes where the food enzyme–TOS remain in the final foods. Chronic exposure to the food enzyme–TOS was calculated by combining the maximum recommended use level with individual consumption data (EFSA CEP Panel, 2021). The estimation involved selection of relevant food categories and application of technical conversion factors (EFSA CEP Panel, 2023). Exposure from all FoodEx categories was subsequently summed up, averaged over the total survey period (days) and normalised for body weight. This was done for all individuals across all surveys, resulting in distributions of individual average exposure. Based on these distributions, the mean and 95th percentile exposures were calculated per survey for the total population and per age class. Surveys with only 1 day per subject were excluded and high‐level exposure/intake was calculated for only those population groups in which the sample size was sufficiently large to allow calculation of the 95th percentile (EFSA, 2011). Table 3 provides an overview of the derived exposure estimates across all surveys. Detailed mean and 95th percentile exposure to the food enzyme–TOS per age class, country and survey, as well as contribution from each FoodEx category to the total dietary exposure are reported in Appendix A – Tables 1 and 2. For the present assessment, food consumption data were available from 48 dietary surveys (covering infants, toddlers, children, adolescents, adults and the elderly), carried out in 26 European countries (Appendix B). The highest dietary exposure was estimated to be 0.463 mg TOS/kg bw per day in adults at the 95th percentile. TABLE 3Summary of the estimated dietary exposure to food enzyme–TOS in six population groups.Population groupEstimated exposure (mg TOS/kg body weight per day)InfantsToddlersChildrenAdolescentsAdultsThe elderly Age range 3–11 months12–35 months3–9 years10–17 years18–64 years≥ 65 years Min–max mean (number of surveys)0.004–0.035 (12)0.017–0.045 (15)0.008–0.040 (19)0.002–0.031 (21)0.017–0.114 (22)0.014–0.061 (23) Min–max 95th percentile (number of surveys)0.017–0.091 (11)0.039–0.079 (14)0.019–0.075 (19)0.006–0.096 (20)0.063–0.463 (22)0.034–0.215 (22)Abbreviation: TOS, total organic solids. Summary of the estimated dietary exposure to food enzyme–TOS in six population groups. Abbreviation: TOS, total organic solids. Uncertainty analysis In accordance with the guidance provided in the EFSA opinion related to uncertainties in dietary exposure assessment (EFSA, 2006), the following sources of uncertainties have been considered and are summarised in Table 4. TABLE 4Qualitative evaluation of the influence of uncertainties on the dietary exposure estimate.Sources of uncertaintiesDirection of impact Model input data Consumption data: different methodologies/representativeness/underreporting/misreporting/no portion size standard+/−Use of data from food consumption surveys of a few days to estimate long‐term (chronic) exposure for high percentiles (95th percentile)+Possible national differences in categorisation and classification of food+/− Model assumptions and factors Exposure to food enzyme–TOS was always calculated based on the recommended maximum use level+Selection of broad FoodEx categories for the exposure assessment+Use of recipe fractions to disaggregate FoodEx categories+/−Use of technical factors in the exposure model+/− Exclusion of one process from the exposure assessment: – production of starch and gluten fractions −Abbreviations: +, uncertainty with potential to cause overestimation of exposure; –, uncertainty with potential to cause underestimation of exposure; TOS, total organic solids. Qualitative evaluation of the influence of uncertainties on the dietary exposure estimate. Exclusion of one process from the exposure assessment: – production of starch and gluten fractions Abbreviations: +, uncertainty with potential to cause overestimation of exposure; –, uncertainty with potential to cause underestimation of exposure; TOS, total organic solids. The conservative approach applied to estimate the exposure to the food enzyme–TOS, in particular assumptions made on the occurrence and use levels of this specific food enzyme, is likely to have led to an overestimation of the exposure. The exclusion of one food manufacturing process from the exposure estimation was based on > 99% of TOS removal. This is not expected to impact on the overall estimate derived. Margin of exposure Since no toxicological assessment was considered necessary by the Panel, a margin of exposure was not calculated. CONCLUSIONS Based on the data provided, the QPS status of the production strain and the absence of concerns arising from the food enzyme manufacturing process, the Panel concluded that the food enzyme endo‐1,4‐β‐xylanase produced with the genetically modified Bacillus subtilis strain AR‐153 does not give rise to safety concerns under the intended conditions of use. The Panel considered the food enzyme free from viable cells of the production organism and recombinant DNA. ABBREVIATIONS body weight Chemical Abstracts Service EFSA Panel on Food Contact Materials, Enzymes and Processing Aids colony forming units European Inventory of Existing Commercial Chemical Substances Food and Agricultural Organization of the United Nations International Union of Biochemistry and Molecular Biology kiloDalton limit of detection qualified presumption of safety sodium dodecyl sulfate‐polyacrylamide gel electrophoresis total organic solids whole genome sequencing World Health Organization REQUESTOR European Commission QUESTION NUMBER EFSA‐Q‐2023‐00307 COPYRIGHT FOR NON‐EFSA CONTENT EFSA may include images or other content for which it does not hold copyright. In such cases, EFSA indicates the copyright holder and users should seek permission to reproduce the content from the original source. PANEL MEMBERS Holger Zorn, José Manuel Barat Baviera, Claudia Bolognesi, Francesco Catania, Gabriele Gadermaier, Ralf Greiner, Baltasar Mayo, Alicja Mortensen, Yrjö Henrik Roos, Marize L. M. Solano, Monika Sramkova, Henk Van Loveren, and Laurence Vernis. LEGAL NOTICE The scientific output published implements EFSA's decision on the confidentiality requests submitted on specific items. As certain items have been awarded confidential status by EFSA, they are consequently withheld from public disclosure by redaction. Supporting information Dietary exposure estimates to the food enzyme–TOS in details